Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Zhao, Hainan; * | Yuan, Hongxia | Wang, Ermin; *
Affiliations: Department of Nephrology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China
Correspondence: [*] Correspondence to: Ermin Wang and Hainan Zhao, Department of Nephrology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, China. E-mail: wangermin1981@163.com (E. Wang), E-mail: bingxue6788@163.com (H. Zhao).
Abstract: Background:Alzheimer’s disease (AD) is the leading cause of dementia. Genetic components play an important role in AD and have been widely evaluated by genome-wide association studies (GWAS) and exome sequencing, and some common and rare genetic variants have been identified. In addition to genetic factors, environment factors have a role in AD. Growing evidence from observational studies linked impaired kidney function to cognitive impairment and AD; however, there are inconsistences in these findings. Objective:To determine the causal effects of impaired kidney function and chronic kidney disease (CKD) on AD. Methods:Mendelian randomization (MR) methods have been widely used to infer causal associations between exposure and outcome. Here, we conducted an MR study to investigate the causal effects of impaired kidney function and CKD on the risk of AD by analyzing large-scale GWAS datasets from FinnGen and CKD Genetics (CKDGen) Consortium. Results:We found no significant but a suggestive effect of CKD on decreased risk of AD using inverse-variance weighted (IVW) (p = 8.46E–02) and simple mode (p = 7.60E–02) methods. We identified a statistically significant effect of the estimated glomerular filtration rate (eGFR) on increased risk of AD using IVW (p = 1.11E–02), weighted median regression (p = 5.60E–03), and weighted mode (p = 2.45E–02) methods. Conclusions:Together, our findings indicate that high eGFR levels may increase the risk of AD. These findings need to be verified in future studies.
Keywords: Alzheimer’s disease, chronic kidney disease, genome-wide association study, kidney function, Mendelian randomization
DOI: 10.3233/JAD-240807
Journal: Journal of Alzheimer's Disease, vol. Pre-press, no. Pre-press, pp. 1-8, 2024
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl